[Bayer](https://www.grants-contributions.bayer.com)

Rolling (monthly review; submit at least 45 days before program start)

No specified maximum; funding based on program scope and proposed budget.

Supports educational programs for healthcare professionals and patients on non-small cell lung cancer, TRK-fusion testing, and precision medicine.

Proposals must align with ACCME guidelines and include detailed educational and budget plans.

--- ## Description Bayer's Oncology Medical Affairs Department invites grant applications for educational programs focused on non-small cell lung cancer (NSCLC), specifically adenocarcinoma. The grant aims to advance knowledge and practice through education on the treatment and management of NSCLC, the role of biomarkers and biomarker-driven testing, and the significance of TRK-fusion and TRK pathway aberrations in cancer. Programs should also address the efficacy and safety of approved TRK inhibitors, strategies for prioritizing treatment, and promote a multi-disciplinary, precision medicine approach, particularly in community and regional healthcare settings. The intended audience includes healthcare professionals (oncologists, pulmonologists, surgeons, pathologists, community HCPs) as well as patients and caregivers. --- ## Due Dates - Rolling submission with monthly review cycles. - Applicants should submit proposals at least 45 days before the intended start of the educational program. - All submissions are reviewed monthly; allow a minimum of 45 days for a decision. --- ## Funding Amount - No explicit maximum or minimum award amount. - Funding is determined based on the scope, educational value, and detailed budget of each proposal. - Programs must include a detailed budget as part of the application. --- ## Eligibility - Open to organizations and individuals capable of delivering accredited continuing education (CE/CME) programs. - Proposals must comply with ACCME guidelines. - Intended for programs targeting healthcare professionals and/or patients/caregivers in the field of non-small cell lung cancer. - Providers must submit proof of accreditation and examples of similar programs in the therapeutic area. --- ## Application Process - Submit applications through the [Bayer grants portal](https://www.grants-contributions.bayer.com/lung-cancer). - Required documentation includes: - Needs assessment - Educational design and rationale - Learning objectives - Proposed faculty - Participant recruitment plan (if applicable) - Outcomes strategy/plan (quarterly reporting required) - Detailed budget - Copy of most recent accreditation letter and status - Sample of other similar educational programs - Applications are reviewed monthly; allow at least 45 days for a response. - Grant recipients must reconcile funding within 60 days of program completion, permit Bayer Medical Affairs to audit live programs, and share activity data and outcomes within 30 days of availability. --- ## Additional Information - Programs must be consistent with current clinical guidelines and literature on NSCLC and TRK-fusion cancers. - Educational content should reflect recent advances in biomarker testing, targeted therapies (including TRK inhibitors), and multidisciplinary precision medicine. - Outcomes reporting is required quarterly. --- ## External Links - [Bayer Lung Cancer Grants Page](https://www.grants-contributions.bayer.com/lung-cancer) - [Bayer Grants & Contributions Portal](https://www.grants-contributions.bayer.com) - [National Comprehensive Cancer Network NSCLC Guidelines](https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf) --- ## Contact Information | Type | Details | |--------------|--------------------------------------------------------------| | Funder Page | [https://www.grants-contributions.bayer.com](https://www.grants-contributions.bayer.com) | | Address | 100 Bayer Boulevard, Whippany, NJ 07981, USA | For specific questions, use the contact form or instructions available on the [Bayer grants portal](https://www.grants-contributions.bayer.com/lung-cancer).

Lung Cancer

Sign in to see full grant listing